Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1991-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.88.19.8405PMID 1924299PMCID PMC52517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• p53 in colorectal cancer: clinicopathological correlation and prognostic significance.

  1991cited by this paper
• Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

  1990cited by this paper
• Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

  1990cited by this paper
• Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.

  1990cited by this paper
• Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

  1990cited by this paper
• Allele loss from chromosome 17 in ovarian cancer.

  1990cited by this paper
• Mechanisms of p53 loss in human sarcomas.

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Structural aspects of the p53 protein in relation to gene evolution.

  1990cited by this paper
• p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

  1990cited by this paper
• Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

  1990cited by this paper
• Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.

  1989cited by this paper
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

  1989cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

  1989cited by this paper
• Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.

  1989cited by this paper
• P53 expression in breast cancer

  1988cited by this paper
• Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations.

  1988cited by this paper
• Allele loss on short arm of chromosome 17 in breast cancers.

  1988cited by this paper
• Identification and localization of mutations at the Lesch-Nyhan locus by ribonuclease A cleavage.

  1987cited by this paper
• Rearrangement of the p53 gene in human osteogenic sarcomas.

  1987cited by this paper
• Sequence-determined DNA separations.

  1984cited by this paper
• DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory.

  1983cited by this paper
• Recursion relation generation of probability profiles for specific‐sequence macromolecules with long‐range correlations

  1974cited by this paper

• From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy

  2024cites this paper
• Differences in somatic TP53 mutation type in breast tumors by race and receptor status

  2021cites this paper
• Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort

  2019cites this paper
• Mutation screening of the TP53 gene by temporal temperature gel electrophoresis (TTGE).

  2014cites this paper
• p53 in the Clinics

  2013cites this paper
• ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia

  2013cites this paper
• Assessing TP53 status in human tumors: Lessons from breast cancer

  2013cites this paper
• DOHÁNYZÁS EREDETŰ DNS KÁROSODÁSOK ÖSSZEFÜGGÉSEINEK VIZSGÁLATA BIOMARKEREKKEL HUMÁN TÜDŐDAGANATOS POPULÁCIÓBAN

  2012cites this paper
• PCR-enriched Differential Display of Gene Variation

  2010cites this paper
• Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis.

  2010cites this paper
• Molecular analysis of mutations in thyroid tumors with TGGE.

  2009cites this paper
• Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts

  2009cites this paper
• MELTING MAPPING IN NANOCHANNELS

  2008cites this paper
• High‐throughput amplicon scanning of the TP53 gene in breast cancer using high‐resolution fluorescent melting curve analyses and automatic mutation calling

  2008cites this paper
• Critical study on the development and design of an automated multicapillary electrophoresis instrument with collection of mutant DNA fractions using Constant Denaturant Capillary Electrophoresis (CDCE)

  2008cites this paper
• Analysis of mutational spectra by denaturing capillary electrophoresis

  2008cites this paper
• Uterine Cervix

  2007cites this paper
• DNA mutation detection with chip-based temperature gradient capillary electrophoresis using a slantwise radiative heating system.

  2007cites this paper
• Association between DNA Repair Gene Polymorphisms and p53 Alterations in Japanese Patients with Muscle-Invasive Bladder Cancer

  2007cites this paper
• High resolution melting for mutation scanning of TP53 exons 5–8

  2007cites this paper
• Evidence for a Gene on l 7 pl 3 . 3 , Distal to TP 53 , as a Target for Allele Loss in Breast Tumors without p 53 Mutations '

  2006cites this paper
• Lung Cancer: Comparison of Two Screening Assays Based on the Polymerase Chain

  2006cites this paper
• Avaliação dos fatores de risco de câncer de cavidade oral e laringe em quatro regiões brasileiras

  2006cites this paper
• The Case of XPD: Sometimes Two Different Mutant Genes Are Better than One

  2006cites this paper
• Frontiers in biochip technology

  2006influential citation
• ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia

  2006cites this paper
• P 53 in Gastric Cancer Base Transitions Are the Most Frequent Genetic Changes at Updated

  2006cites this paper
• Mutations of the p 53 Gene Do Not Occur in Testis Cancer 1

  2006influential citation
• Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death

  2005cites this paper
• Genetics of Bone Mineralization and Morphology in Inbred Mice: Analysis of the HcB/Dem Recombinant Congenic Strains

  2005cites this paper
• Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings

  2005cites this paper
• Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis.

  2005cites this paper
• TP53 alterations in atypical ductal hyperplasia and ductal carcinomain situ of the breast

  2005cites this paper
• Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.

  2005cites this paper
• Structural factors determining DNA length limitations in conformation‐sensitive mutation detection methods

  2005cites this paper
• Aberrations of theAPC gene in primary breast carcinoma

  2005cites this paper
• Genetic diversity and evolutionary age of parthenogenetic oribatid mites (Acari: Oribatida)

  2004cites this paper
• Detection of p53 gene mutation in plasma of patients with gastric cancer

  2004cites this paper
• PROBING SINGLE DNA MOLECULE TRANSPORT USING FABRICATED NANOPORES.

  2004cites this paper
• Leader Biological indices in the assessment of breast cancer

  2003cites this paper
• Overexpression of Cyclin A Overrides the Effect of p53 Alterations in Breast Cancer Patients with Long Follow-up Time

  2003cites this paper
• Fast Screening of Single-Nucleotide Polymorphisms Using Chip-Based Temperature Gradient Capillary Electrophoresis

  2003cites this paper
• 사람의 ε-글로빈 프로모트에서 d(CXG)와 d(GXC)의 안정성에 인접한 염기 서열들의 영향에 관한 연구

  2002cites this paper
• Establishment of quick-methods to reveal DNA-polymorphisms: single strand conformational polymorphism (SSCP) and heteroduplex analysis (HA)

  2002cites this paper
• Homogeneous amplification and mutation scanning of the p53 gene using fluorescent melting curves.

  2002cites this paper
• p 53 in Hematologic Malignancies

  2002cites this paper
• Mutations in Leukemia and Myelodysplastic Syndrome after Ovarian Cancer 1

  2002cites this paper
• Real-time PCR technology for cancer diagnostics.

  2002cites this paper
• Melting gel techniques in single nucleotide polymorphism and mutation detection: From theory to automation

  2002cites this paper
• Denaturing gradient gel electrophoresis.

  2002cites this paper
• PCR Mutation Detection Protocols

  2002cites this paper
• p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer.

  2002cites this paper
• Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer

  2002cites this paper
• GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene.

  2001cites this paper
• GSTM 1 , GSTT 1 , and GSTP 1 Genotypes in Relation to Breast Cancer Risk and Frequency of Mutations in the p 53 Gene 1

  2001cites this paper
• p53: an overview of over two decades of study.

  2001cites this paper
• Scanning for point variation in large populations by melt-MADGE

  2001cites this paper
• Mechanisms of oncogenesis in colon versus rectal cancer

  2001cites this paper
• Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors

  2001cites this paper
• Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.

  2001cites this paper
• P53 mutations analysis in benign and malignant breast lesions: Using needle rinses from fine‐needle aspirations

  2000cites this paper
• Enrichment Methods for Mutation Detection

  2000cites this paper
• Cellular and Tissue Markers in Solid Tumors

  2000cites this paper
• Molecular Biological Analyses and Molecular Pathology in Clinical Chemistry

  2000cites this paper
• Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.

  2000cites this paper
• Recurrent Fallopian Tube Carcinoma: TP53 Mutation and Clinical Course

  2000cites this paper
• Two-point fluorescence detection and automated fraction collection applied to constant denaturant capillary electrophoresis.

  2000cites this paper
• Detection of p53 mutations in Hong Kong colorectal carcinomas by conventional PCR-SSCP analysis versus p53 yeast functional assays.

  1999cites this paper
• Comparative identity and homogeneity testing of the mtDNA HV1 region using denaturing gradient gel electrophoresis.

  1999cites this paper
• Analysis of the p53 Status of Tumors : An Overview of Methods.

  1999cites this paper
• Benchmarks Higher Sensitivity of Denaturing Gradient Gel Electrophoresis than Sequencing in the Detection of Mutations in DNA from Tumor Samples

  1999cites this paper
• Detection of low-frequency mutations in exon 8 of the TP53 gene by constant denaturant capillary electrophoresis (CDCE).

  1999cites this paper
• Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE.

  1999cites this paper
• Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma

  1999cites this paper
• Detection of mutations and polymorphisms in clotting factors by denaturing gradient gel electrophoresis.

  1999influential citation
• Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.

  1999cites this paper
• p21WAF1/CIP1expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival

  1999cites this paper
• Detection of Mutations by Denaturing Gradient Gel Electrophoresis

  1998cites this paper
• Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.

  1998cites this paper
• Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening

  1998cites this paper
• Higher sensitivity of denaturing gradient gel electrophoresis than sequencing in the detection of mutations in DNA from tumor samples.

  1998cites this paper
• p53 mutagenesis in Klatskin tumors.

  1998cites this paper
• MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.

  1998cites this paper
• Multiple myeloma in three siblings.

  1998cites this paper
• Mutation analysis of the adenomatous polyposis coli gene

  1998cites this paper
• Detecting single base substitutions, mismatches and bulges in DNA by temperature gradient gel electrophoresis and related methods.

  1998cites this paper
• Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations.

  1998cites this paper
• BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.

  1998cites this paper
• p53 Mutations and DNA Ploidy in Colorectal Adenocarcinomas

  1998cites this paper
• TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.

  1998cites this paper
• Detection of mutations in mycobacteria by PCR-SSCP (single-strand conformation polymorphism).

  1998cites this paper
• Correlation between apoptosis and TP53 status in osteosarcoma.

  1998cites this paper
• Molecular markers in entomology

  1998cites this paper
• A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer.

  1997cites this paper
• Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients.

  1997cites this paper
• Mutation Testing of Early-Onset Breast Cancer Genes BRCA1 and BRCA2

  1997influential citation
• Expression profile of MDM‐2 proteins in chronic lymphocytic leukemia and their clinical relevance

  1997cites this paper
• p53 mutations in breast cancer: incidence and relations to tumor aggressiveness and evolution of the disease.

  1997cites this paper
• p53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases

  1997cites this paper
• Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer.

  1997cites this paper